2022 - Research.com Best Female Scientist Award
Nancy E. Kemeny focuses on Colorectal cancer, Internal medicine, Surgery, Chemotherapy and Gastroenterology. Her Colorectal cancer study deals with the bigger picture of Cancer. Her Internal medicine study integrates concerns from other disciplines, such as Oncology and Pathology.
Her study in the field of Systemic chemotherapy is also linked to topics like In patient. Her studies deal with areas such as Artery, Leukocytosis and Toxicity as well as Gastroenterology. In her research, Physical therapy is intimately related to Randomized controlled trial, which falls under the overarching field of Hepatic arterial infusion.
Her primary areas of investigation include Internal medicine, Colorectal cancer, Chemotherapy, Oncology and Surgery. Internal medicine is often connected to Gastroenterology in her work. The various areas that Nancy E. Kemeny examines in her Gastroenterology study include Carcinoembryonic antigen, Carcinoma, Pathology and Toxicity.
Her biological study spans a wide range of topics, including Radiation therapy, Hepatectomy, Metastasis and Survival rate. Her Chemotherapy study combines topics in areas such as Artery, Rectum, Regimen, Adjuvant and Disease. Her Oncology research is multidisciplinary, relying on both KRAS, Clinical trial, Incidence and Adjuvant therapy.
Her primary scientific interests are in Internal medicine, Colorectal cancer, Chemotherapy, Oncology and Gastroenterology. Her study in the fields of Hepatic arterial infusion, Disease, KRAS and Intrahepatic Cholangiocarcinoma under the domain of Internal medicine overlaps with other disciplines such as In patient. Colorectal cancer is a subfield of Cancer that Nancy E. Kemeny investigates.
Her research on Chemotherapy concerns the broader Surgery. Her Oncology research includes themes of BAP1, Incidence, Hepatocellular carcinoma, Hazard ratio and Radiation therapy. Nancy E. Kemeny has researched Gastroenterology in several fields, including Survival rate, Surgical oncology, Proportional hazards model and Cumulative incidence.
Her primary areas of study are Internal medicine, Colorectal cancer, Oncology, Chemotherapy and KRAS. Her work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Hepatectomy and other disciplines. Specifically, her work in Colorectal cancer is concerned with the study of Hepatic arterial infusion.
Her Oncology research includes elements of Cancer, Metastasis, Incidence, Univariate analysis and Hazard ratio. Her Chemotherapy study introduces a deeper knowledge of Surgery. Nancy E. Kemeny has included themes like Germline mutation and Krukenberg tumor in her Surgery study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
R.K. Portenoy;H.T. Thaler;A.B. Kornblith;J. McCarthy Lepore.
European Journal of Cancer (1994)
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Gershon Y. Locker;Stanley R Hamilton;Jules Harris;John M. Jessup.
Journal of Clinical Oncology (2006)
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
Ki Young Chung;Jinru Shia;Nancy E. Kemeny;Manish Shah.
Journal of Clinical Oncology (2005)
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
Robert C. Bast;Peter Ravdin;Daniel F. Hayes;Susan Bates.
Journal of Clinical Oncology (2001)
CD133 expression is not restricted to stem cells, and both CD133 + and CD133 – metastatic colon cancer cells initiate tumors
Sergey V. Shmelkov;Jason M. Butler;Andrea T. Hooper;Adilia Hormigo.
Journal of Clinical Investigation (2008)
Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
James S. Tomlinson;William R. Jarnagin;Ronald P. DeMatteo;Yuman Fong.
Journal of Clinical Oncology (2007)
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
Nancy Kemeny;Ying Huang;Alfred M. Cohen;Weiji Shi.
The New England Journal of Medicine (1999)
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Daniel F. Hayes;Daniel F. Hayes;Robert C. Bast;Christopher E. Desch;Herbert Fritsche.
Journal of the National Cancer Institute (1996)
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
Nancy Kemeny;John Daly;Bonnie Reichman;Nancy Geller.
Annals of Internal Medicine (1987)
Symptom prevalence, characteristics and distress in a cancer population
R. K. Portenoy;H. T. Thaler;A. B. Kornblith;J. McCarthy Lepore.
Quality of Life Research (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: